Jonathan Edwards
Senior Member (Voting Rights)
Haven’t read the paper but is it not slightly problematic to have a very different proportion of sexes in control vs test group?
They seem to be using two control groups - female matched and a further male comparison also analysed for BV/HR correlations.
It looks quite a nice study from the abstract at least. The question for me would be to what extent their POTS cohort might be relevant to ME/CFS OI patients.